GTC Biotherapeutics (fka GTCB)

[cash2go]

Time to focus on LFB Biotechnologies

They have been pumping millions into GTC for a long time.

GTC Biotherapeutics (GTCB) Says France's LFB Biotechnologies To Invest $25 Million
10/2/2006

Impressive drug they have been cooperating on I wasn't aware of:

Background on rhFVIIa

The total worldwide sales of the current recombinant factor VIIa product in all indications were reported to be $845 million (US) in 2005. An independent market research report estimates the worldwide sales of rhFVIIa will reach $2 billion (US) by 2012. Both plasma-derived and recombinant products are used in treating hemophilia caused by genetic conditions in which patients' failure to express enough coagulation factors on their own may lead to excessive bleeding. The application of transgenic technology may enable the production and pricing of rhFVIIa at appropriate levels for broader utilization of rhFVIIa, as well as expanding its use to the treatment of the unmet needs of patients in developing countries and to the treatment of other acquired bleeding conditions.

http://www.allbusiness.com/medicine-health/diseases-disorders-musculoskeletal/5069160-1.html